Alife's AI Technology Now Available on Hamilton Thorne Laser Systems
Alife's AI Technology Now Available on Hamilton Thorne Laser Systems
The partnership between Hamilton Thorne, Inc. & Alife Health aims to expand access to cutting-edge AI technology to support clinical decision making
漢密爾頓索恩公司與Alife Health的合作旨在擴展先進人工智能科技,以支持臨床決策
SAN FRANCISCO and BEVERLY, Mass., Oct. 3, 2024 /PRNewswire/ -- Alife Health, the leading technology company building AI tools to advance in-vitro fertilization (IVF) in the US today, announced a marketing partnership with Hamilton Thorne, Inc., which manufactures and markets precision laser systems, imaging systems, consumables, and services that enable breakthroughs in Assisted Reproductive Technologies (ART) and Developmental Biology Research markets.
舊金山和馬薩諸塞州貝弗利,2024年10月3日/PRNewswire/ -- Alife Health,這家領先的科技公司正在構建AI工具,以推動美國體外受精(IVF)技術,今天宣佈與 漢密爾頓索恩公司,該公司生產和銷售精密激光系統、成像系統、耗材和服務,幫助體外輔助生殖技術(ART)和發育生物學研究市場取得重大突破。
Through this partnership, Alife's Embryo Assist software will be available on Hamilton Thorne laser systems to enable embryologists to seamlessly create digital records of every embryo as well as leverage Alife's Clinical Decision Support (CDS) algorithm to determine the best embryo for transfer. As part of the partnership, all US-based Hamilton Thorne clients will receive a three month trial of the Embryo Assist technology.
通過這一合作,Alife的 胚胎助手 軟件將可在Hamilton Thorne激光系統上使用,使胚胎學家能夠無縫創建每個胚胎的數字記錄,並利用Alife的臨床決策支持(CDS)算法來判斷最佳可以轉移的胚胎。作爲合作伙伴關係的一部分,所有總部位於美國的Hamilton Thorne客戶將獲得胚胎輔助技術的三個月試用期。
"Hamilton Thorne is dedicated to leveraging cutting-edge industry expertise to continually enhance our comprehensive suite of products and services," says Catherine Welch, VP of Clinical Sales & Customer Success (Americas) for Hamilton Thorne. "We prioritize partnerships with forward-thinking companies and top industry experts to collaborate on ways to expand customer-centric solutions that bring innovations to life."
"Hamilton Thorne致力於利用尖端行業專業知識,不斷改善我們全面的產品和服務組合," Catherine Welch,Hamilton Thorne的臨床銷售和客戶成功(美洲)副總裁表示。"我們優先選擇與有遠見的公司和頂尖行業專家合作,共同探討擴展以客戶爲中心的解決方案的方式,將創新付諸現實。"
The Embryo Assist software is a microscope-integrated tool, allowing embryologists to easily capture embryo images and data to elevate laboratory quality-control measures. The software also boasts a CDS-based AI embryo ranking feature, which utilizes machine learning to help embryologists determine which embryos have the highest likelihood of success. Alife's award-nominated scientific abstract regarding the CDS model, demonstrates non-inferior performance to manual embryo grading by highly experienced embryologists. This indicates the tool can offer laboratories a new level of standardization for embryo selection.
胚胎輔助軟件是一個與顯微鏡集成的工具,使胚胎學家能夠輕鬆捕獲胚胎圖像和數據,提高實驗室質量控制措施。該軟件還擁有基於CDS的人工智能胚胎排名功能,利用機器學習幫助胚胎學家判斷哪些胚胎具有最高成功概率。Alife的獲獎提名的科學摘要,展示了CDS模型相對於經驗豐富的胚胎學家手動分級的非劣效能。這表明該工具可以爲實驗室提供新的胚胎選擇標準化水平。 科學摘要 關於CDS模型,Alife展示了與經驗豐富的胚胎學家手動胚胎分級相當的性能。這表明該工具可以爲實驗室提供新的胚胎選擇標準化水平。
"At Alife, we value the opportunity to partner with industry leaders with a demonstrated history of excellence in reproductive medicine," says Melissa Teran, COO and Head of Product for Alife Health. "We are thrilled to partner with Hamilton Thorne to advance our mutual goal of using technology to provide the most effective care for individuals seeking to grow their family."
"在Alife,我們重視與在生殖醫學領域具有卓越歷史的行業領先者合作的機會," Alife Health首席運營官兼產品負責人Melissa Teran表示。"我們很高興與Hamilton Thorne合作,共同推進我們使用技術爲尋求擴大家庭的個人提供最有效護理的共同目標。"
About Alife Health
關於Alife Health
Alife's mission is to personalize and modernize the IVF process with cutting-edge artificial intelligence technology to improve outcomes and care for all. The company has built a consortium of partnerships with the top clinics and most renowned physicians to bring significant clinical improvements to patients globally. Alife has been recognized as one of Fast Company's Most Innovative Companies of 2024. Founded in 2020, the company is based in San Francisco and backed by top-tier venture capital investors including Lux Capital, Union Square Ventures and Maveron. To learn more visit .
Alife的使命是利用尖端人工智能技術個性化和現代化體外受精(IVF)過程,以改善所有人的結局和護理。該公司已經與頂級診所和最負盛名的醫生建立了合作伙伴關係,爲全球患者帶來重大的臨床改進。Alife被認爲是《Fast Company》2024年最具創新性公司之一。公司成立於2020年,總部設在舊金山,由Lux Capital、Union Square Ventures和Maveron等頂尖創投投資者支持。欲了解更多信息,請訪問。
About Hamilton Thorne, Inc.
關於Hamilton Thorne, Inc.
Hamilton Thorne Inc. (HTI) manufactures and markets precision laser systems, CASA systems (Computer Assisted Sperm Analysis), imaging systems, consumables, and services that enable breakthroughs in Assisted Reproductive Technologies (ART) and Developmental Biology Research markets. Over thirty years ago, HTI started as a small business serving the animal breeding market and embarked on a mission to provide innovations that improve quality of life. Since then, HTI has expanded to the fertility industry and strives to create sustainable products that support IVF professionals worldwide. Our diverse customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotech companies, and other commercial and academic research establishments.
Hamilton Thorne 計算機-半導體公司(HTI)是一家生產和銷售精密鐳射系統、casa systems(計算機輔助精子分析)、成像系統、耗材和服務的公司,這些產品使輔助生殖技術(ART)和發育生物學研究市場取得突破。30多年前,HTI作爲一家爲動物繁殖市場提供服務的小型企業起步,開始致力於提供改善生活質量的創新。此後,HTI已擴展到生育行業,並努力創造可持續發展的產品,支持全球試管嬰兒專業人士。我們多元化的客戶群包括生育診所、大學研究中心、動物繁育設施、藥品公司、生物技術公司以及其他商業和學術研究機構。
Contact Info
Alife Health: Jamie Gray, [email protected]
Hamilton Thorne: Catherine Welch, [email protected]
聯繫信息
Alife Health: Jamie Gray [email protected]
Hamilton Thorne: Catherine Welch [email protected]
SOURCE Alife Health
SOURCE Alife Health
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?
譯文內容由第三人軟體翻譯。